Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines

Different liver cell types are endowed with immunological properties, including cell-intrinsic innate immune functions that are important to initially control pathogen infections. However, a full landscape of expression and functionality of the innate immune signaling pathways in the major human liver cells is still missing. In order to comparatively characterize these pathways, we purified primary human hepatocytes, hepatic stellate cells, liver sinusoidal endothelial cells (LSEC), and Kupffer cells (KC) from human liver resections. We assessed mRNA and protein expression level of the major innate immune sensors, as well as checkpoint-inhibitor ligands in the purified cells, and found Toll-like receptors (TLR), RIG-I-like receptors, as well as several DNA cytosolic sensors to be expressed in the liver microenvironment. Amongst the cells tested, KC were shown to be most broadly active upon stimulation with PRR ligands emphasizing their predominant role in innate immune sensing the liver microenvironment. By KC immortalization, we generated a cell line that retained higher innate immune functionality as compared to THP1 cells, which are routinely used to study monocyte/macrophages functions. Our findings and the establishment of the KC line will help to understand immune mechanisms behind antiviral effects of TLR agonists or checkpoint inhibitors, which are in current preclinical or clinical development.

[1]  Silvia Guzmán-Beltrán,et al.  High glucose induces O‐GlcNAc glycosylation of the vitamin D receptor (VDR) in THP1 cells and in human macrophages derived from monocytes , 2017, Cell biology international.

[2]  Xue-mei Ma,et al.  TLR7 and TLR8 agonist resiquimod (R848) differently regulates MIF expression in cells and organs , 2017, Cytokine.

[3]  K. Moraes,et al.  Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis , 2017, Cell biology international.

[4]  F. Grossi,et al.  Understanding the checkpoint blockade in lung cancer immunotherapy. , 2017, Drug discovery today.

[5]  P. Mantecca,et al.  Airborne Nanoparticle Release and Toxicological Risk from Metal-Oxide-Coated Textiles: Toward a Multiscale Safe-by-Design Approach. , 2017, Environmental Science and Technology.

[6]  Benhong Xu,et al.  Quantitative proteomic profiling for clarification of the crucial roles of lysosomes in microbial infections , 2017, Molecular immunology.

[7]  S. Friedman,et al.  Mechanisms of hepatic stellate cell activation , 2017, Nature Reviews Gastroenterology &Hepatology.

[8]  Z. Hou,et al.  A Programmed Cell Death‐1 Haplotype is Associated with Clearance of Hepatitis B Virus , 2017, Annals of clinical and laboratory science.

[9]  T. Greten,et al.  Tumor regulation of the tissue environment in the liver , 2017, Pharmacology & therapeutics.

[10]  F. Tacke,et al.  Liver macrophages in tissue homeostasis and disease , 2017, Nature Reviews Immunology.

[11]  J. Mann,et al.  Epigenetics and Liver Fibrosis , 2017, Cellular and molecular gastroenterology and hepatology.

[12]  K. Breckpot,et al.  PD1 signal transduction pathways in T cells , 2017, Oncotarget.

[13]  K. Breckpot,et al.  PD1 signal transduction pathways in T cells , 2017, Oncotarget.

[14]  Z. Temesgen,et al.  Sofosbuvir/velpatasvir fixed-dose combination for the treatment of chronic hepatitis C virus infection. , 2017, Drugs of today.

[15]  G. Yoo,et al.  PD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case report , 2016, Journal of Immunotherapy for Cancer.

[16]  A. Medvedev,et al.  Molecular mechanisms of regulation of Toll‐like receptor signaling , 2016, Journal of leukocyte biology.

[17]  T. Yamashita,et al.  The future of immunotherapy for sarcoma , 2016, Expert opinion on biological therapy.

[18]  E. Assenat,et al.  NOD1 Participates in the Innate Immune Response Triggered by Hepatitis C Virus Polymerase , 2016, Journal of Virology.

[19]  F. Zoulim,et al.  New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus. , 2016, Journal of hepatology.

[20]  F. Ginhoux,et al.  Tissue-Resident Macrophage Ontogeny and Homeostasis. , 2016, Immunity.

[21]  J. Korbel,et al.  Immortalization capacity of HPV types is inversely related to chromosomal instability , 2016, OncoTarget.

[22]  F. Bertucci,et al.  The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers , 2016, Oncoimmunology.

[23]  Jennifer L. Anderson,et al.  Prospective immunotherapies in childhood sarcomas: PD1/PDL1 blockade in combination with tumor vaccines , 2016, Pediatric Research.

[24]  M. Ait-goughoulte,et al.  Early inhibition of hepatocyte innate responses by hepatitis B virus. , 2015, Journal of hepatology.

[25]  M. Ait-goughoulte,et al.  Expression and functionality of Toll- and RIG-like receptors in HepaRG cells. , 2015, Journal of hepatology.

[26]  Anh-Hoa Nguyen,et al.  Safety, Pharmacokinetics and Pharmacodynamics of the Oral Toll-Like Receptor 7 Agonist GS-9620 in Treatment-Naive Patients with Chronic Hepatitis C , 2015, Antiviral therapy.

[27]  B. Smedsrød,et al.  Liver Sinusoidal Endothelial Cells. , 2015, Comprehensive Physiology.

[28]  C. Coffin,et al.  The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection. , 2015, Journal of hepatology.

[29]  F. Zoulim,et al.  P0535 : Direct antiviral effects of various pattern recognition receptor (PRR) agonists in HBV-replicating hepatocytes , 2015 .

[30]  F. Zoulim,et al.  An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium. , 2014, Biochemical and biophysical research communications.

[31]  S. Akira,et al.  Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. , 2014, Cold Spring Harbor perspectives in biology.

[32]  C. Figdor,et al.  Human Plasmacytoid Dendritic Cells: From Molecules to Intercellular Communication Network , 2013, Front. Immunol..

[33]  Z. Shusen,et al.  Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B , 2012, BMC Gastroenterology.

[34]  Percy A. Knolle,et al.  Living in the liver: hepatic infections , 2012, Nature Reviews Immunology.

[35]  M. Odenthal,et al.  Toll‐like receptor 2–mediated innate immune response in human nonparenchymal liver cells toward adeno‐associated viral vectors , 2012, Hepatology.

[36]  I. N. Crispe,et al.  Liver antigen-presenting cells. , 2011, Journal of hepatology.

[37]  T. Billiar,et al.  Hepatocytes express functional NOD1 and NOD2 receptors: a role for NOD1 in hepatocyte CC and CXC chemokine production. , 2010, Journal of hepatology.

[38]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[39]  D. Bienzle,et al.  Structure and function of programmed death (PD) molecules. , 2010, Veterinary immunology and immunopathology.

[40]  E. Alexandre,et al.  Isolation and culture of primary hepatocytes from resected human liver tissue. , 2010, Methods in molecular biology.

[41]  I. N. Crispe,et al.  The liver as a lymphoid organ. , 2009, Annual review of immunology.

[42]  F. Zoulim,et al.  Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. , 2009, The Journal of general virology.

[43]  Mustapha Si-Tahar,et al.  Cutting Edge: Influenza A Virus Activates TLR3-Dependent Inflammatory and RIG-I-Dependent Antiviral Responses in Human Lung Epithelial Cells1 , 2007, The Journal of Immunology.

[44]  T. Iftner,et al.  TLR9 Expression and Function Is Abolished by the Cervical Cancer-Associated Human Papillomavirus Type 161 , 2007, The Journal of Immunology.

[45]  M. Severa,et al.  Tumor Necrosis Factor Alpha Enhances Influenza A Virus-Induced Expression of Antiviral Cytokines by Activating RIG-I Gene Expression , 2006, Journal of Virology.

[46]  S. Friedman,et al.  Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis , 2004, Gut.

[47]  Z. Kmieć,et al.  Cooperation of Liver Cells in Health and Disease , 2001, Advances in Anatomy Embryology and Cell Biology.

[48]  K. Takeda,et al.  The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses , 2000, Immunological reviews.

[49]  J. Köhrle,et al.  The selenoprotein thioredoxin reductase is expressed in peripheral blood monocytes and THP1 human myeloid leukemia cells ‐ regulation by 1,25‐dihydroxyvitamin D3 and selenite , 1999, BioFactors.

[50]  T. Yamane,et al.  Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. , 1984, Gan.

[51]  Ivan Damjanov,et al.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line , 1979, Nature.